https://wikimd.org/index.php?action=history&feed=atom&title=Odalasvir 2026-04-27T01:21:59Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Odalasvir&diff=6294236&oldid=prev 2025-02-15T11:04:40Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 11:04, 15 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">'''</del>Odalasvir<del style="font-weight: bold; text-decoration: none;">''' is an [[antiviral drug]] that was under development for the treatment of [[Hepatitis C]]. It is a [[NS5A inhibitor]], a type of drug that interferes with the replication of the Hepatitis C virus. </del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{DISPLAYTITLE:</ins>Odalasvir<ins style="font-weight: bold; text-decoration: none;">}}</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>==<del style="font-weight: bold; text-decoration: none;">Development</del>==</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>== <ins style="font-weight: bold; text-decoration: none;">Overview </ins>==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Odalasvir <del style="font-weight: bold; text-decoration: none;">was developed by </del>[[<del style="font-weight: bold; text-decoration: none;">Achillion Pharmaceuticals</del>]]<del style="font-weight: bold; text-decoration: none;">, a biopharmaceutical company based in the United States</del>. <del style="font-weight: bold; text-decoration: none;">The drug was part of </del>a <del style="font-weight: bold; text-decoration: none;">combination therapy with other antiviral drugs, such as [[Sofosbuvir]] and </del>[[<del style="font-weight: bold; text-decoration: none;">Velpatasvir</del>]], <del style="font-weight: bold; text-decoration: none;">for </del>the <del style="font-weight: bold; text-decoration: none;">treatment </del>of <del style="font-weight: bold; text-decoration: none;">Hepatitis </del>C.  </div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">'''</ins>Odalasvir<ins style="font-weight: bold; text-decoration: none;">''' is an investigational antiviral drug that is being studied for the treatment of </ins>[[<ins style="font-weight: bold; text-decoration: none;">Hepatitis C virus|Hepatitis C</ins>]] <ins style="font-weight: bold; text-decoration: none;">infections</ins>. <ins style="font-weight: bold; text-decoration: none;">It is </ins>a [[<ins style="font-weight: bold; text-decoration: none;">NS5A inhibitor</ins>]], <ins style="font-weight: bold; text-decoration: none;">which means it targets </ins>the <ins style="font-weight: bold; text-decoration: none;">non-structural protein 5A (NS5A) </ins>of <ins style="font-weight: bold; text-decoration: none;">the hepatitis </ins>C <ins style="font-weight: bold; text-decoration: none;">virus, a protein essential for viral replication</ins>.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>==<del style="font-weight: bold; text-decoration: none;">Clinical Trials</del>==</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>== <ins style="font-weight: bold; text-decoration: none;">Mechanism of Action </ins>==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">In clinical trials</del>, <del style="font-weight: bold; text-decoration: none;">Odalasvir showed promising results in reducing </del>the <del style="font-weight: bold; text-decoration: none;">levels </del>of the Hepatitis C virus in the <del style="font-weight: bold; text-decoration: none;">body</del>. <del style="font-weight: bold; text-decoration: none;">However</del>, the <del style="font-weight: bold; text-decoration: none;">development </del>of the <del style="font-weight: bold; text-decoration: none;">drug was discontinued </del>in <del style="font-weight: bold; text-decoration: none;">2017 due to the emergence of more effective treatments for Hepatitis C</del>.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Odalasvir works by inhibiting the NS5A protein</ins>, <ins style="font-weight: bold; text-decoration: none;">which is crucial for </ins>the <ins style="font-weight: bold; text-decoration: none;">replication </ins>of the <ins style="font-weight: bold; text-decoration: none;">[[</ins>Hepatitis C virus<ins style="font-weight: bold; text-decoration: none;">]]. NS5A is involved </ins>in the <ins style="font-weight: bold; text-decoration: none;">assembly of the viral replication complex and the modulation of host cell processes</ins>. <ins style="font-weight: bold; text-decoration: none;">By inhibiting this protein</ins>, <ins style="font-weight: bold; text-decoration: none;">odalasvir disrupts </ins>the <ins style="font-weight: bold; text-decoration: none;">replication cycle </ins>of the <ins style="font-weight: bold; text-decoration: none;">virus, thereby reducing viral load </ins>in <ins style="font-weight: bold; text-decoration: none;">infected individuals</ins>.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>==<del style="font-weight: bold; text-decoration: none;">Mechanism of Action</del>==</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>== <ins style="font-weight: bold; text-decoration: none;">Chemical Structure </ins>==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">As a NS5A inhibitor, Odalasvir works by binding to the </del>[[<del style="font-weight: bold; text-decoration: none;">NS5A protein</del>]]<del style="font-weight: bold; text-decoration: none;">, </del>a <del style="font-weight: bold; text-decoration: none;">viral protein </del>that <del style="font-weight: bold; text-decoration: none;">plays a crucial role in </del>the <del style="font-weight: bold; text-decoration: none;">replication </del>of the <del style="font-weight: bold; text-decoration: none;">Hepatitis C virus. By inhibiting this protein</del>, <del style="font-weight: bold; text-decoration: none;">Odalasvir prevents the virus from replicating and spreading in the body</del>.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[<ins style="font-weight: bold; text-decoration: none;">File:Odalasvir_structure.svg|thumb|right|Chemical structure of Odalasvir</ins>]]</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Odalasvir has </ins>a <ins style="font-weight: bold; text-decoration: none;">complex chemical structure </ins>that <ins style="font-weight: bold; text-decoration: none;">allows it to effectively bind to </ins>the <ins style="font-weight: bold; text-decoration: none;">NS5A protein. The structure </ins>of <ins style="font-weight: bold; text-decoration: none;">odalasvir is designed to fit into </ins>the <ins style="font-weight: bold; text-decoration: none;">binding site of NS5A</ins>, <ins style="font-weight: bold; text-decoration: none;">thereby blocking its function</ins>.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>==<del style="font-weight: bold; text-decoration: none;">Side Effects</del>==</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>== <ins style="font-weight: bold; text-decoration: none;">Clinical Development </ins>==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">Like </del>other antiviral <del style="font-weight: bold; text-decoration: none;">drugs, Odalasvir may cause side </del>effects<del style="font-weight: bold; text-decoration: none;">. These can include fatigue, headache, </del>and <del style="font-weight: bold; text-decoration: none;">nausea. However, </del>the <del style="font-weight: bold; text-decoration: none;">severity and frequency </del>of <del style="font-weight: bold; text-decoration: none;">these side effects can vary among individuals</del>.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Odalasvir is currently undergoing clinical trials to evaluate its efficacy and safety in treating [[Hepatitis C]]. It is often studied in combination with </ins>other antiviral <ins style="font-weight: bold; text-decoration: none;">agents to enhance its therapeutic </ins>effects and <ins style="font-weight: bold; text-decoration: none;">to prevent </ins>the <ins style="font-weight: bold; text-decoration: none;">development </ins>of <ins style="font-weight: bold; text-decoration: none;">drug resistance</ins>.</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>==<del style="font-weight: bold; text-decoration: none;">See Also</del>==</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>== <ins style="font-weight: bold; text-decoration: none;">Potential Benefits ==</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* [[Hepatitis C]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">The use of odalasvir in combination with other antiviral drugs has shown promise in achieving sustained virologic response (SVR) in patients with [[Hepatitis C]]. This means that the virus becomes undetectable in the blood of patients after treatment, indicating a potential cure.</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Side Effects ==</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">As with many antiviral medications, odalasvir may have side effects. Common side effects observed in clinical trials include headache, fatigue, and nausea. The safety profile of odalasvir is still being evaluated in ongoing studies.</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">== Related Pages </ins>==</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* [[Hepatitis C <ins style="font-weight: bold; text-decoration: none;">virus]]</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* [[NS5A inhibitor</ins>]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [[Antiviral drug]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* [[Antiviral drug]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">* [[NS5A inhibitor]]</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">* [[Achillion Pharmaceuticals]]</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Antiviral drugs]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Antiviral drugs]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Hepatitis C]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Hepatitis C <ins style="font-weight: bold; text-decoration: none;">treatments</ins>]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">[[Category:Pharmaceuticals]]</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">{{Pharma-stub}}</del></div></td><td colspan="2" class="diff-side-added"></td></tr> </table>

Prab https://wikimd.org/index.php?title=Odalasvir&diff=5340895&oldid=prev 2024-03-02T03:43:04Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Odalasvir&#039;&#039;&#039; is an [[antiviral drug]] that was under development for the treatment of [[Hepatitis C]]. It is a [[NS5A inhibitor]], a type of drug that interferes with the replication of the Hepatitis C virus. <br /> <br /> ==Development==<br /> Odalasvir was developed by [[Achillion Pharmaceuticals]], a biopharmaceutical company based in the United States. The drug was part of a combination therapy with other antiviral drugs, such as [[Sofosbuvir]] and [[Velpatasvir]], for the treatment of Hepatitis C. <br /> <br /> ==Clinical Trials==<br /> In clinical trials, Odalasvir showed promising results in reducing the levels of the Hepatitis C virus in the body. However, the development of the drug was discontinued in 2017 due to the emergence of more effective treatments for Hepatitis C.<br /> <br /> ==Mechanism of Action==<br /> As a NS5A inhibitor, Odalasvir works by binding to the [[NS5A protein]], a viral protein that plays a crucial role in the replication of the Hepatitis C virus. By inhibiting this protein, Odalasvir prevents the virus from replicating and spreading in the body.<br /> <br /> ==Side Effects==<br /> Like other antiviral drugs, Odalasvir may cause side effects. These can include fatigue, headache, and nausea. However, the severity and frequency of these side effects can vary among individuals.<br /> <br /> ==See Also==<br /> * [[Hepatitis C]]<br /> * [[Antiviral drug]]<br /> * [[NS5A inhibitor]]<br /> * [[Achillion Pharmaceuticals]]<br /> <br /> [[Category:Antiviral drugs]]<br /> [[Category:Hepatitis C]]<br /> [[Category:Pharmaceuticals]]<br /> {{Pharma-stub}}</div>

Prab